Followers | 373 |
Posts | 16793 |
Boards Moderated | 3 |
Alias Born | 03/07/2014 |
Monday, August 08, 2022 4:29:57 PM
HORRIFICALLY BAD - like plane crash with a car crash wrapped around it kinda bad LMAO !!!
"Hearing aids" = a SHITTY BUSINESS as proven by ALL these dilution mills that MAKE NO PROFIT SELLING THEM !!!
EAR is going to DILUTE THE SHIT OUT OF THEIR STOCK and the only other scam-n-sham "public traded" so called "Hearing Aid Company" I'm aware of is doing THE EXACT SAME THING w/ that epic POS surpassing 8 BILLION SHARES printed and issued within the next month or two.
PROVING "hearing aid sales" is a NON PROFIT and LOW MARGIN POS "business" - nothing but SHARE PRINTING SCAMS and never scale well or have decent margins.
The damn RATE OF PRODUCT RETURN and BAD PRODUCT NEEDING SERVICE is staggering in the EAR report (SAME for all these CHINA INC Xiamen Sound Alibaba import/middle-man 2-bit knock off sellers) - which is THE NORM as all the crap these POS companies sell is CHINA INC middle-man garbage !!
EAR might be a flip when it gets done diluting and is probably sitting at 50 CENTS max or so - and even then it's gonna be risky as hell until they can show they've stopped bleeding cash and DILUTING.
Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.
Recent EAR News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/26/2024 06:39:45 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 02/21/2024 05:44:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 11:03:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 11:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:59:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:56:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:50:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:47:43 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 02/16/2024 04:34:26 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/16/2024 04:30:56 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 02/16/2024 02:58:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 01:42:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 10:09:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/07/2024 11:00:52 AM
- Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings • GlobeNewswire Inc. • 01/31/2024 01:00:00 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 01/16/2024 10:22:24 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 01/16/2024 09:46:25 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 01/05/2024 10:09:16 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 01/05/2024 09:06:05 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 12/28/2023 05:24:35 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 12/28/2023 04:21:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 12:38:28 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/01/2023 09:03:51 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM